VASO Corp (VASO)
VASO is quoted over the counter, not listed on an exchange. VASO Corp files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | VASO, quoted over the counter |
| SEC CIK | 0000839087 |
| OTC Markets tier | OTCQX (price source, 2026-11-13) |
| SEC industry code | Electromedical & Electrotherapeutic Apparatus |
| Business address | Plainview, NY |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-08-14 |
| Cash and burn | $38.3M cash; operating cash flow $2.0M a quarter. | Report 2026-06-30 |
| Shares outstanding | 176,018,035 (2026-08-12); 175,753,035 a year earlier; 175,141,005 three years earlier. | Cover page 2026-08-12 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | UHY LLP, Sterling Heights, Michigan, United States | PCAOB Form AP 2026-04-09 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $11.2M | $544K | $17.4M | $38.3M | $147K | $80.2M | 10-Q 2026-08-14 |
| Q1 2026 2026-03-31 | $19.4M | -$887K | -$12.6M | $22.0M | $290K | $89.0M | 10-Q 2026-05-15 |
| Q4 2025 2025-12-31 | $27.0M | $1.1M | $261K | $34.1M | $572K | $89.1M | 10-K 2026-03-31 |
| Q3 2025 2025-09-30 | $22.7M | $1.7M | $2.8M | $34.9M | $562K | $89.1M | 10-Q 2025-11-14 |
| Q2 2025 2025-06-30 | $20.0M | -$197K | $6.8M | $32.6M | $2.0M | $87.2M | 10-Q 2025-08-14 |
| Q1 2025 2025-03-31 | $19.5M | -$1.1M | -$566K | $25.3M | $4K | $87.5M | 10-Q 2026-05-15 |
| Q4 2024 2024-12-31 | $27.0M | $2.1M | -$367K | $26.3M | $12K | $86.8M | 10-K 2026-03-31 |
| Q3 2024 2024-09-30 | $20.8M | -$1.2M | $1.9M | $26.8M | $8K | $81.7M | 10-Q 2025-11-14 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2005-09-01 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-11-16 |
| Latest current report | 8-K/A | 2026-08-06 |
| Latest proxy | DEFA14A | 2026-10-29 |
Source: SEC EDGAR submissions feed, 509 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier